Lung Neoplasms: all 7,334 studies
Page 43 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Imaging Tumor-infiltrating T-cells in Non-small Cell Lung CancerCompletedNCT03853187Phase 2
- A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung CancerCompletedNCT03850067Phase 1
- Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)TerminatedNCT03849950Not applicable
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsCompletedNCT03849469Phase 1
- The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound ImagingCompletedNCT03849040
- CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).Status unknownNCT03848611Phase 2
- A Study to Evaluate Immunotherapy Combinations in Participants With Lung CancerCompletedNCT03846310Phase 1
- Her2-positive Lung Cancer Treated With Dedicated DrugCompletedNCT03845270Phase 2
- Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung CancerStatus unknownNCT03841136Phase 2
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung CancerStatus unknownNCT03840408Not applicable
- KN046 in Patients With Advanced Non-small Cell Lung CancerTerminatedNCT03838848Phase 2
- Maximal Exercise Capacity and Extra-pulmonary Characteristics in Patients With Lung Cancer With Complete Remission .CompletedNCT03838757
- The Tracking Molecular Evolution for NSCLC (T-MENC) StudyStatus unknownNCT03838588
- Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung CancerCompletedNCT03837600
- Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in BrazilCompletedNCT03836469
- Resistance Inspiratory Muscle Training for Patients With Thoracic MalignanciesCompletedNCT03834116Not applicable
- Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI ResistanceActive, not recruitingNCT03833440Phase 2
- Moderate Hypofractionated Radiotherapy for Lung CancerStatus unknownNCT03833193Not applicable
- Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR MutationActive, not recruitingNCT03833154Phase 3
- Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyActive, not recruitingNCT03830918Phase 1/2
- Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer DiagnosisCompletedNCT03830619
- A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing ChemotherapyStatus unknownNCT03830411Phase 2
- FGFR Inhibitor in FGFR Dysregulated CancerTerminatedNCT03827850Phase 2
- Dry Pleurodesis With Talcum and Afatinib is Used to Treat Patients With Non-Small Cell Lung CarcinomaStatus unknownNCT03827070Phase 1
- Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) EffectCompletedNCT03825510Phase 2
- Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer SurgeryCompletedNCT03824977
- An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC)Status unknownNCT03823625Phase 2
- S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung CancerCompletedNCT03823118Phase 2
- Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)CompletedNCT03820557Not applicable
- A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal CancerCompletedNCT03819387Phase 1
- Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLCTerminatedNCT03818776Early Phase 1
- A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsCompletedNCT03811652Phase 1
- The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03811054Phase 2
- Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)CompletedNCT03810066Phase 2
- Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung CancerStatus unknownNCT03808701Phase 1
- Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%Status unknownNCT03808480Phase 2
- First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung CancerActive, not recruitingNCT03804580Phase 2
- Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community SettingWithdrawnNCT03804255
- The Real Word Study of Albumin-binding Taxol for Lung Cancer TreatmentStatus unknownNCT03802409
- Electromagnetic Navigation Versus CT Guided TTNA in the Diagnosis of Early Peripheral Lung CancerStatus unknownNCT03802266Not applicable
- Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment FailureCompletedNCT03802240Phase 3
- A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung CancerActive, not recruitingNCT03800134Phase 3
- Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS StudyCompletedNCT03798743Phase 2
- Prospective Genomics Initiative on Multiple Synchronous Lung Cancer (PGI-MSLC)Status unknownNCT03795155
- Inpatient Smokers and LDCT Screening Part 2CompletedNCT03793894Not applicable
- Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerActive, not recruitingNCT03793179Phase 3
- Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based RegimenWithdrawnNCT03792503Phase 4
- To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung CancerStatus unknownNCT03792074Phase 3
- Pharmacogenetics in Non Small Cell Lung CancerStatus unknownNCT03791151
- Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positiveCompletedNCT03790397
- Reducing Insulin, Growth Hormones, and TumorsTerminatedNCT03785808Not applicable
- Continued Access to RXDX-105CompletedNCT03784378Phase 1
- Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung CancerStatus unknownNCT03781869Phase 2
- Evaluation of Use of Diagnostic AI for Lung Cancer in PracticeStatus unknownNCT03780582Not applicable
- Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLCStatus unknownNCT03780283Phase 2
- Alectinib in Combination With Bevacizumab in ALK Positive NSCLCCompletedNCT03779191Phase 2
- Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLCStatus unknownNCT03778138Phase 2
- PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving ChemotherapyStatus unknownNCT03776604Not applicable
- A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing ChemotherapyCompletedNCT03776032Phase 3
- Breathe Anew for Lung Cancer SurvivorshipCompletedNCT03773380Phase 1
- An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual DiseaseWithdrawnNCT03770299Phase 2
- Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLCActive, not recruitingNCT03769103Phase 2
- Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M NegativeStatus unknownNCT03765775Phase 2
- NGS Combined With RNAseq on Tumor Immune Escape in NSCLCStatus unknownNCT03764917
- Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)TerminatedNCT03762122Phase 2
- Expanded Access to NanoPacNo longer availableNCT03756311
- SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung CancerStatus unknownNCT03755115Phase 2
- A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.CompletedNCT03755102Early Phase 1
- IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis StudyCompletedNCT03753724
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)CompletedNCT03752398Phase 1
- Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung CancerStatus unknownNCT03751592Phase 1/2
- Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung CancerStatus unknownNCT03750916Phase 2
- Innovative Approach to Reduce Lung Cancer StigmaCompletedNCT03750864Not applicable
- Yorkshire Enhanced Stop Smoking StudyCompletedNCT03750110Not applicable
- NLCR in Prediction of the Grade of Lung Tumor.CompletedNCT03749512
- Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung CancerStatus unknownNCT03749213Phase 2
- Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung CancerCompletedNCT03746262
- Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029）CompletedNCT03743129Phase 2
- Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line ImmunotherapyCompletedNCT03741868
- Sleep Apnea and Lung CancerStatus unknownNCT03741647
- PET/MR Imaging in Lung CancerTerminatedNCT03739281Not applicable
- Anlotinib in Treatment of Recurrent Small Cell Lung CancerStatus unknownNCT03732846Phase 2
- Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain MetastasesStatus unknownNCT03732482Phase 2/3
- A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLCStatus unknownNCT03732001Phase 2
- Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing TreatmentActive, not recruitingNCT03731585Not applicable
- A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung CancerCompletedNCT03728556Phase 3
- Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine CancerCompletedNCT03728361Phase 2
- Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung CancerStatus unknownNCT03727867Phase 3
- Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving LorlatinibCompletedNCT03727477
- A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer PatientsCompletedNCT03725475
- Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung CancerActive, not recruitingNCT03724500
- Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung CancerCompletedNCT03721120Not applicable
- NEUWAVE Flexible Probe Study #2WithdrawnNCT03713099Not applicable
- Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLCTerminatedNCT03711422Phase 1
- Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)Status unknownNCT03711305Phase 3
- Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerActive, not recruitingNCT03707938Phase 1
- Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyCompletedNCT03707574
- Rh-Endostatin (Endostar®) Continuous Intravenous InfusionStatus unknownNCT03706703Phase 2
- Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLCStatus unknownNCT03706287Phase 1/2